STOCK TITAN

INmune Bio: Highbridge reports 4.98% via warrants

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Inmune Bio, Inc. (INMB) is the issuer in an amended Schedule 13G in which Highbridge Capital Management, LLC reported beneficial ownership of 1,454,400 shares of its common stock issuable upon exercise of warrants, or 4.98% of the class. The warrants are directly held by the Highbridge Funds, which Highbridge advises. The percentage calculation uses 27,753,789 INmune Bio shares outstanding as of August 6, 2026, and assumes exercise of the warrants.

Reported beneficial ownership 1,454,400 shares INmune Bio common shares issuable upon exercise of warrants directly held by the Highbridge Funds.
Percentage of class 4.98% Calculated assuming exercise of the warrants.
Shares outstanding 27,753,789 shares INmune Bio common shares outstanding as of August 6, 2026; used in the ownership percentage calculation.
beneficial ownership regulatory
"Amount beneficially owned"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
warrants financial
"Common Stock issuable upon exercise of warrants"
Warrants are special documents that give you the right to buy a company's stock at a set price before a certain date. They are often used as a way for companies to attract investors or raise money, and their value can increase if the company's stock price goes up.
Sole Voting Power regulatory
"Sole Voting Power 1,454,400.00"
Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.
Sole Dispositive Power regulatory
"Sole Dispositive Power 1,454,400.00"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many INMB shares did Highbridge report beneficially owning?

Highbridge Capital Management, LLC reported beneficial ownership of 1,454,400 INmune Bio common shares, equal to 4.98% of the class. The shares are issuable upon exercise of warrants held directly by the Highbridge Funds.

Does Highbridge say it directly holds INMB common shares?

The reported common shares are issuable upon exercise of warrants directly held by the Highbridge Funds, of which Highbridge Capital Management, LLC is the investment adviser. Highbridge states that the report is not an admission that it or the other persons mentioned is a beneficial owner for purposes of Section 13 of the Securities Exchange Act of 1934.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





45782T105

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: Reflects shares of Common Stock (as defined in Item 2(a)) issuable upon exercise of warrants.


SCHEDULE 13G



Highbridge Capital Management, LLC
Signature:/s/ Kirk Rule
Name/Title:By: Kirk Rule, Executive Director
Date:11/16/2026

Keep reading